| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |